j.boateng
Submits third-party assay reports on material purchased directly. Based in Kaunas.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.11%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043533 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | VendorInvestigate | 2026-Q2 | 97.96 | 5.07 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042567 | Tirzepatide | ERP | ERP-2512-T7433 | Janoshik | 2026-Q2 | 99.11 | 1.29 | 95.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019638 | Semaglutide | Homopeptide | HOMO-2508-K2535 | Janoshik | 2025-Q4 | 99.48 | 3.49 | 97.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019626 | Semaglutide | Homopeptide | HOMO-2505-N2173 | Janoshik | 2025-Q4 | 98.94 | 5.55 | 91.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020369 | KPV | MKM | MKM-2504-N3869 | Janoshik | 2025-Q2 | 99.25 | 5.97 | 103.4 | Supplier-supplied | 1 | FAIL |
| AX-2024-004210 | Survodutide | WWB | WWB-2408-T3710 | Janoshik | 2024-Q4 | 99.32 | 2.56 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004687 | TB-500 | TFC | TFC-2405-J8155 | Janoshik | 2024-Q3 | 98.82 | 2.20 | 107.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004306 | Sermorelin | QYB | QYB-2404-W5163 | Janoshik | 2024-Q2 | 99.15 | 4.05 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004772 | N-Acetyl Semax Amide | Homopeptide | HOMO-2401-X1480 | Janoshik | 2024-Q1 | 99.07 | 8.62 | 93.5 | Supplier-supplied | 0 | PASS |